ResultsIQ

ResultsIQ › Latest results › Acutaas Chemicals Limited

Acutaas Chemicals Limited Q3 FY26 results press release summary

NSE: ACUTAAS · BSE: 543349

Results press release of 28 Jan 2026, summarised by AI from the filing.

Revenue growth guidance revised upward from 25% to approximately 30%, supported by a healthy order book and improved visibility.

Key takeaways

  1. FY26 guidance Revenue growth guidance revised upward from 25% to approximately 30%, supported by a healthy order book and improved visibility.
  2. Gross margin Gross margin improved to 57.0% in Q3 FY26, up 1,073 bps YoY.
  3. CDMO ramp-up Growth momentum driven by the continued ramp-up of the CDMO business.
  4. New verticals Battery chemicals and semiconductor chemicals verticals are under active capital investment, progressing steadily toward scale.

Original filing on BSE

Acutaas Chemicals Limited Q1 FY27 results

As filed: Revenue ₹330 cr (+59% year on year), EBITDA ₹113 cr (+122% year on year), PAT ₹75.0 cr (+70% year on year), EBITDA margin 34.3% (+966 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹422 cr, EBITDA ₹181 cr, PAT ₹137 cr, EBITDA margin 43.0%. Not scored. No result for the same quarter last year. Share price after the results: +25.2% in 29 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹391 cr, EBITDA ₹154 cr, PAT ₹112 cr, EBITDA margin 39.5%. Not scored. No result for the same quarter last year. Share price after the results: +30.9% in 30 days (Nifty 500: +1.5%).
  • Q2 FY26: Revenue ₹305 cr, EBITDA ₹97.0 cr, PAT ₹73.0 cr, EBITDA margin 31.8%. Not scored. No result for the same quarter last year. Share price after the results: +10.2% in 28 days (Nifty 500: +1.2%).
  • Q1 FY26: Revenue ₹206 cr, EBITDA ₹51.0 cr, PAT ₹45.0 cr, EBITDA margin 24.8%. Not scored. No result for the same quarter last year. Share price after the results: +20.5% in 30 days (Nifty 500: −2.4%).

Past price moves after results do not indicate future moves. Not a recommendation.

Acutaas Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.